Rosuvastatin Withdrawn Phase 4 Trials for Dyslipidemia (Fredrickson Type Ⅱa) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00396240ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals